BLENREP Effectiveness and Safety in Multiple Myeloma (BEaMM) – Real-World Evidence on Patients Taking Belantamab Mafodotin in Europe (217240) First published 10/05/2022 Last updated 12/03/2025 EU PAS number:EUPAS44701 Study Finalised